"we were fully aware of the fact that our twins would be the first babies in the world to receive this treatment in utero," corinna said..
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
phil lempert: it's affordability. it's convenience. it's not having a lot of waste. people are more concerned about waste than ever before..